NCT00804271View on ClinicalTrials.gov

Memantine and Validation of a New Alzheimer's Disease Scale

PHASE3CompletedINTERVENTIONAL
Enrollment

487

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Alzheimer's Disease
Interventions
DRUG

memantine

memantine tablets, OD, 12 weeks

Trial Locations (1)

01307

University Clinic Gustav Carus, Dresden

Sponsors
All Listed Sponsors
lead

Merz Pharmaceuticals GmbH

INDUSTRY

NCT00804271 - Memantine and Validation of a New Alzheimer's Disease Scale | Biotech Hunter | Biotech Hunter